5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.97▲ | 0.97▲ | 0.97▲ | 1.05▼ | 1.01▼ |
MA10 | 0.98▼ | 0.98▼ | 1.00▼ | 1.00▼ | 1.00▼ |
MA20 | 1.00▼ | 1.03▼ | 1.07▼ | 1.00▼ | 1.11▼ |
MA50 | 1.04▼ | 1.05▼ | 1.01▼ | 0.99▼ | 1.33▼ |
MA100 | 1.08▼ | 1.00▼ | 1.00▼ | 1.13▼ | 1.35▼ |
MA200 | 1.01▼ | 1.01▼ | 0.99▼ | 1.34▼ | 2.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.007▼ | -0.017▼ | 0.005▲ | 0.007▲ |
RSI | 37.310▼ | 33.761▼ | 38.010▼ | 47.147▼ | 42.408▼ |
STOCH | 15.218▼ | 5.486▼ | 4.332▼ | 50.669 | 30.477 |
WILL %R | -70.043 | -84.792▼ | -92.738▼ | -82.201▼ | -81.960▼ |
CCI | -38.992 | -60.278 | -78.231 | -21.688 | -12.871 |
Monday, July 14, 2025 04:08 AM
Iron Mountain Incorporated (NYSE: IRM), a global leader in information management services, will report its second quarter 2025 financial results before market hours on Wednesday, August 6, 2025. The ...
|
Wednesday, July 09, 2025 04:39 PM
Get the latest Iterum Therapeutics plc (ITRM) stock news and headlines to help you in your trading and investing decisions.
|
Wednesday, July 02, 2025 01:30 PM
Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum” or the “Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/07/25 | 1.04 | 1.04 | 0.9636 | 0.9775 | 832,345 |
14/07/25 | 1.12 | 1.13 | 0.9992 | 1.00 | 945,824 |
11/07/25 | 1.09 | 1.28 | 1.09 | 1.13 | 1,915,953 |
10/07/25 | 1.06 | 1.0885 | 1.04 | 1.08 | 504,202 |
09/07/25 | 0.9325 | 1.07 | 0.93 | 1.06 | 1,017,572 |
08/07/25 | 0.932 | 0.9359 | 0.912 | 0.933 | 446,468 |
07/07/25 | 0.941 | 0.95 | 0.92 | 0.9237 | 557,709 |
03/07/25 | 0.97 | 0.978 | 0.94 | 0.9639 | 491,961 |
02/07/25 | 0.9777 | 0.9792 | 0.95 | 0.968 | 457,304 |
01/07/25 | 0.99 | 0.99 | 0.97 | 0.9746 | 358,772 |
|
|
||||
|
|
||||
|
|